SCHEMBL21701915

SCHEMBL21701915

N#Cc1cccc2c1-c1c(-c3ccc(-c4cc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cccc1C21c2ccccc2Sc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
NTSR1 P30989 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
ADORA1 P30542 5/20 0.35
ADORA2A P29274 4/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
MAPK1 P28482 1/20 0.35
SQOR Q9Y6N5 3/20 0.34
PIM1 P11309 1/20 0.34
PPARG P37231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701977 0.94 PDK2 (0.36) MEN1KMT2AGABRG2GABRB3GABRA5
SCHEMBL21702004 0.91 ABCG2 (0.44) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL23257137 0.89 HPGD (0.35) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21342872 0.89 HPGD (0.35) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21343123 0.88 MEN1 (0.33) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL23257652 0.88 PDK2 (0.35) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL23257065 0.88 PDK2 (0.35) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL23257080 0.88 MEN1 (0.33) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21342757 0.88 MEN1 (0.33) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL23256854 0.88 MEN1 (0.34) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME CRY1, CRY2, CYP1A1 MEN1 319/4885KMT2A 1024/4885HPGD 1496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.